Innotech Gets FDA OK for Laser Skin-Perforator

PURCHASE, N.Y., July 22 -- Diabetics now have a needle-free method to obtain routine blood samples. Innotech USA Inc. has received a 510(k) concurrence letter from the FDA permitting it to market its FriendlyLight LightLance Laser Skin-Perforator for use in hospitals, offices and homes.

"Tens of millions of times each day, millions of persons with diabetes in the US have to suffer though the recurrent lancing of their fingertips and alternate sites using decades-old steel lancet technologies," said Pavel Efremkin, Innotech CEO. "Now our miniaturized medical laser technologies will enable persons with diabetes and clinicians to easily and safely obtain capillary blood samples with significantly increased comfort and control -- without the use or fear of a needle."